Elanco Animal Health (ELAN) Short Interest Up 54.1% in February

Share on StockTwits

Elanco Animal Health (NASDAQ:ELAN) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 54,173,571 shares, a growth of 54.1% from the February 15th total of 35,150,581 shares. Approximately 75.1% of the shares of the company are sold short. Based on an average daily volume of 12,286,650 shares, the days-to-cover ratio is currently 4.4 days.

Shares of NASDAQ ELAN opened at $30.64 on Friday. Elanco Animal Health has a fifty-two week low of $28.00 and a fifty-two week high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last announced its quarterly earnings data on Wednesday, February 6th. The company reported $0.29 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.03. The company had revenue of $799.30 million during the quarter, compared to analyst estimates of $804.07 million. Elanco Animal Health’s revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.12 earnings per share.

ELAN has been the subject of several recent research reports. BMO Capital Markets reduced their price target on Elanco Animal Health from $37.00 to $32.00 and set a “market perform” rating for the company in a research note on Wednesday, December 19th. They noted that the move was a valuation call. Argus initiated coverage on Elanco Animal Health in a research note on Tuesday, January 15th. They issued a “buy” rating and a $37.00 price target for the company. UBS Group initiated coverage on Elanco Animal Health in a research note on Wednesday, January 23rd. They issued a “sell” rating and a $29.00 price target for the company. Credit Suisse Group restated a “hold” rating and issued a $36.00 price target on shares of Elanco Animal Health in a research note on Monday, December 17th. Finally, William Blair initiated coverage on Elanco Animal Health in a research note on Monday, February 11th. They issued a “market perform” rating and a $29.71 price target for the company. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $33.48.

In other news, Director R David Hoover purchased 20,000 shares of Elanco Animal Health stock in a transaction that occurred on Wednesday, March 13th. The stock was acquired at an average cost of $31.43 per share, for a total transaction of $628,600.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

A number of hedge funds and other institutional investors have recently made changes to their positions in ELAN. Focused Wealth Management Inc acquired a new position in Elanco Animal Health in the 4th quarter valued at $32,000. First Hawaiian Bank acquired a new position in Elanco Animal Health in the 4th quarter valued at $35,000. American International Group Inc. acquired a new position in shares of Elanco Animal Health during the 4th quarter worth $48,000. Public Employees Retirement Association of Colorado acquired a new position in shares of Elanco Animal Health during the 4th quarter worth $83,000. Finally, Metropolitan Life Insurance Co. NY acquired a new position in shares of Elanco Animal Health during the 4th quarter worth $112,000.

WARNING: This piece was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4224827/elanco-animal-health-elan-short-interest-up-54-1-in-february.html.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Featured Article: 12b-1 Fees

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Deutsche Boerse  Hits New 52-Week High at $124.50
Deutsche Boerse Hits New 52-Week High at $124.50
MoSys Inc.  Short Interest Update
MoSys Inc. Short Interest Update
Critical Review: AltiGen Communications  vs. Clearone
Critical Review: AltiGen Communications vs. Clearone
Bovis Homes Group  Lowered to “Sell” at Shore Capital
Bovis Homes Group Lowered to “Sell” at Shore Capital
Atalaya Mining  Stock Rating Reaffirmed by Peel Hunt
Atalaya Mining Stock Rating Reaffirmed by Peel Hunt
Brokers Set Expectations for YASKAWA ELEC CO/ADR’s FY2020 Earnings
Brokers Set Expectations for YASKAWA ELEC CO/ADR’s FY2020 Earnings


© 2006-2019 Ticker Report